Closing Bell: Medicenna Therapeutics Corp up on Thursday (MDNA)

Today during trading, shares of Medicenna Therapeutics Corp opened at $2.16 and closed at $2.28. It traded at a low of $2.16 to a high of $2.56.

Shares boosted 7.04 percent from the previous day's close of $2.13.

Today across North America, the TSX Composite closed -1.68% at 22723.21, the S&P 500 closed 1.58% at 5522.30, the Dow Jones Industrial Average closed 0.24% at 40842.79 and the Nasdaq Composite closed 2.64% at 17599.40.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 231,999 shares was traded during the session, with total trades of 420, with an average volume of 92,443 in the last five days.

The TSX market on the whole today saw 907 price advancers against 4,327 declines and 72 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, in the last 12 months, Medicenna Therapeutics Corp's shares have risen 286.44%, while they have risen 442.86% year-to-date.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $159.28 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Based on 2.00 analysts, Medicenna Therapeutics Corp gets an average recommendation of "Strong Buy" according to Zacks. From those 2 analysts, 2 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..